The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rapid Antigen Testing (RAT) for COVID-19 Market Research Report 2025
Synopsis
The global Rapid Antigen Testing (RAT) for COVID-19 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rapid Antigen Testing (RAT) for COVID-19 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Antigen Testing (RAT) for COVID-19 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rapid Antigen Testing (RAT) for COVID-19 include Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion and AESKU.GROUP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rapid Antigen Testing (RAT) for COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Antigen Testing (RAT) for COVID-19.
Report Scope
The Rapid Antigen Testing (RAT) for COVID-19 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Antigen Testing (RAT) for COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Antigen Testing (RAT) for COVID-19 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Quidel
ACCESS BIO
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
ROCHE
BD
OraSure Technologies
Clip Health
LumiraDx
Princeton BioMeditech Corporation
RapiGEN Inc.
Orient Gene
Wondfo Biotech
Ihealth (Andon Health)
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology
Segment by Type
Fluorescence Immunochromatography
Colloidal Gold Immunochromatography
Latex Immunochromatography
Others
Segment by Application
Hospitals
Community Testing
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rapid Antigen Testing (RAT) for COVID-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rapid Antigen Testing (RAT) for COVID-19 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Rapid Antigen Testing (RAT) for COVID-19 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rapid Antigen Testing (RAT) for COVID-19 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Antigen Testing (RAT) for COVID-19 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rapid Antigen Testing (RAT) for COVID-19 include Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion and AESKU.GROUP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rapid Antigen Testing (RAT) for COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Antigen Testing (RAT) for COVID-19.
Report Scope
The Rapid Antigen Testing (RAT) for COVID-19 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Antigen Testing (RAT) for COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Antigen Testing (RAT) for COVID-19 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Quidel
ACCESS BIO
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
ROCHE
BD
OraSure Technologies
Clip Health
LumiraDx
Princeton BioMeditech Corporation
RapiGEN Inc.
Orient Gene
Wondfo Biotech
Ihealth (Andon Health)
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology
Segment by Type
Fluorescence Immunochromatography
Colloidal Gold Immunochromatography
Latex Immunochromatography
Others
Segment by Application
Hospitals
Community Testing
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rapid Antigen Testing (RAT) for COVID-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rapid Antigen Testing (RAT) for COVID-19 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rapid Antigen Testing (RAT) for COVID-19 Market Overview
1.1 Product Overview and Scope of Rapid Antigen Testing (RAT) for COVID-19
1.2 Rapid Antigen Testing (RAT) for COVID-19 Segment by Type
1.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Type (2024-2030)
1.2.2 Fluorescence Immunochromatography
1.2.3 Colloidal Gold Immunochromatography
1.2.4 Latex Immunochromatography
1.2.5 Others
1.3 Rapid Antigen Testing (RAT) for COVID-19 Segment by Application
1.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Community Testing
1.3.4 Other
1.4 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size Estimates and Forecasts
1.4.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue 2019-2030
1.4.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales 2019-2030
1.4.3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rapid Antigen Testing (RAT) for COVID-19 Market Competition by Manufacturers
2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Average Price by Manufacturers (2019-2024)
2.4 Global Rapid Antigen Testing (RAT) for COVID-19 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Product Type & Application
2.7 Rapid Antigen Testing (RAT) for COVID-19 Market Competitive Situation and Trends
2.7.1 Rapid Antigen Testing (RAT) for COVID-19 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rapid Antigen Testing (RAT) for COVID-19 Players Market Share by Revenue
2.7.3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rapid Antigen Testing (RAT) for COVID-19 Retrospective Market Scenario by Region
3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region: 2019-2030
3.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region: 2019-2024
3.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region: 2025-2030
3.3 Global Rapid Antigen Testing (RAT) for COVID-19 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2019-2030
3.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2019-2024
3.3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2025-2030
3.4 North America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.4.1 North America Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2030)
3.4.3 North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.5.1 Europe Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2030)
3.5.3 Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.6.1 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2030)
3.6.3 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.7.1 Latin America Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2030)
3.7.3 Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.8.1 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2019-2030)
4.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2019-2024)
4.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2025-2030)
4.1.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2019-2030)
4.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2019-2030)
4.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2019-2024)
4.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2025-2030)
4.2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2019-2030)
4.3 Global Rapid Antigen Testing (RAT) for COVID-19 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2019-2030)
5.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2019-2024)
5.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2025-2030)
5.1.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2019-2030)
5.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2019-2030)
5.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2019-2024)
5.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2025-2030)
5.2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2019-2030)
5.3 Global Rapid Antigen Testing (RAT) for COVID-19 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Quidel
6.2.1 Quidel Corporation Information
6.2.2 Quidel Description and Business Overview
6.2.3 Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Quidel Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.2.5 Quidel Recent Developments/Updates
6.3 ACCESS BIO
6.3.1 ACCESS BIO Corporation Information
6.3.2 ACCESS BIO Description and Business Overview
6.3.3 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.3.5 ACCESS BIO Recent Developments/Updates
6.4 CTK Biotech
6.4.1 CTK Biotech Corporation Information
6.4.2 CTK Biotech Description and Business Overview
6.4.3 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.4.5 CTK Biotech Recent Developments/Updates
6.5 SD Biosensor
6.5.1 SD Biosensor Corporation Information
6.5.2 SD Biosensor Description and Business Overview
6.5.3 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.5.5 SD Biosensor Recent Developments/Updates
6.6 Ellume
6.6.1 Ellume Corporation Information
6.6.2 Ellume Description and Business Overview
6.6.3 Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ellume Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.6.5 Ellume Recent Developments/Updates
6.7 InBios
6.6.1 InBios Corporation Information
6.6.2 InBios Description and Business Overview
6.6.3 InBios Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 InBios Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.7.5 InBios Recent Developments/Updates
6.8 Celltrion
6.8.1 Celltrion Corporation Information
6.8.2 Celltrion Description and Business Overview
6.8.3 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.8.5 Celltrion Recent Developments/Updates
6.9 AESKU.GROUP
6.9.1 AESKU.GROUP Corporation Information
6.9.2 AESKU.GROUP Description and Business Overview
6.9.3 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.9.5 AESKU.GROUP Recent Developments/Updates
6.10 ROCHE
6.10.1 ROCHE Corporation Information
6.10.2 ROCHE Description and Business Overview
6.10.3 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.10.5 ROCHE Recent Developments/Updates
6.11 BD
6.11.1 BD Corporation Information
6.11.2 BD Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.11.3 BD Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BD Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.11.5 BD Recent Developments/Updates
6.12 OraSure Technologies
6.12.1 OraSure Technologies Corporation Information
6.12.2 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.12.3 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.12.4 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.12.5 OraSure Technologies Recent Developments/Updates
6.13 Clip Health
6.13.1 Clip Health Corporation Information
6.13.2 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.13.3 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.13.5 Clip Health Recent Developments/Updates
6.14 LumiraDx
6.14.1 LumiraDx Corporation Information
6.14.2 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.14.3 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.14.4 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.14.5 LumiraDx Recent Developments/Updates
6.15 Princeton BioMeditech Corporation
6.15.1 Princeton BioMeditech Corporation Corporation Information
6.15.2 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.15.3 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.15.5 Princeton BioMeditech Corporation Recent Developments/Updates
6.16 RapiGEN Inc.
6.16.1 RapiGEN Inc. Corporation Information
6.16.2 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.16.3 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.16.4 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.16.5 RapiGEN Inc. Recent Developments/Updates
6.17 Orient Gene
6.17.1 Orient Gene Corporation Information
6.17.2 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.17.3 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.17.5 Orient Gene Recent Developments/Updates
6.18 Wondfo Biotech
6.18.1 Wondfo Biotech Corporation Information
6.18.2 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.18.3 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.18.5 Wondfo Biotech Recent Developments/Updates
6.19 Ihealth (Andon Health)
6.19.1 Ihealth (Andon Health) Corporation Information
6.19.2 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.19.3 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.19.5 Ihealth (Andon Health) Recent Developments/Updates
6.20 Wantai BioPharm
6.20.1 Wantai BioPharm Corporation Information
6.20.2 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.20.3 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.20.5 Wantai BioPharm Recent Developments/Updates
6.21 Biotest Biotech
6.21.1 Biotest Biotech Corporation Information
6.21.2 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.21.3 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.21.5 Biotest Biotech Recent Developments/Updates
6.22 Shenzhen YHLO Biotech
6.22.1 Shenzhen YHLO Biotech Corporation Information
6.22.2 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.22.3 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.22.5 Shenzhen YHLO Biotech Recent Developments/Updates
6.23 Vazyme Biotech
6.23.1 Vazyme Biotech Corporation Information
6.23.2 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.23.3 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.23.5 Vazyme Biotech Recent Developments/Updates
6.24 EasyDiagnosis Biomedicine
6.24.1 EasyDiagnosis Biomedicine Corporation Information
6.24.2 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.24.3 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.24.4 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.24.5 EasyDiagnosis Biomedicine Recent Developments/Updates
6.25 Beijing Hotgen Biotech
6.25.1 Beijing Hotgen Biotech Corporation Information
6.25.2 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.25.3 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.25.5 Beijing Hotgen Biotech Recent Developments/Updates
6.26 Assure Tech
6.26.1 Assure Tech Corporation Information
6.26.2 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.26.3 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.26.5 Assure Tech Recent Developments/Updates
6.27 Hangzhou AllTest Biotech
6.27.1 Hangzhou AllTest Biotech Corporation Information
6.27.2 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.27.3 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.27.5 Hangzhou AllTest Biotech Recent Developments/Updates
6.28 ACON Biotech
6.28.1 ACON Biotech Corporation Information
6.28.2 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.28.3 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.28.4 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.28.5 ACON Biotech Recent Developments/Updates
6.29 BGI Genomics
6.29.1 BGI Genomics Corporation Information
6.29.2 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.29.3 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.29.4 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.29.5 BGI Genomics Recent Developments/Updates
6.30 Lepu Medical Technology
6.30.1 Lepu Medical Technology Corporation Information
6.30.2 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Description and Business Overview
6.30.3 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.30.4 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.30.5 Lepu Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rapid Antigen Testing (RAT) for COVID-19 Industry Chain Analysis
7.2 Rapid Antigen Testing (RAT) for COVID-19 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rapid Antigen Testing (RAT) for COVID-19 Production Mode & Process
7.4 Rapid Antigen Testing (RAT) for COVID-19 Sales and Marketing
7.4.1 Rapid Antigen Testing (RAT) for COVID-19 Sales Channels
7.4.2 Rapid Antigen Testing (RAT) for COVID-19 Distributors
7.5 Rapid Antigen Testing (RAT) for COVID-19 Customers
8 Rapid Antigen Testing (RAT) for COVID-19 Market Dynamics
8.1 Rapid Antigen Testing (RAT) for COVID-19 Industry Trends
8.2 Rapid Antigen Testing (RAT) for COVID-19 Market Drivers
8.3 Rapid Antigen Testing (RAT) for COVID-19 Market Challenges
8.4 Rapid Antigen Testing (RAT) for COVID-19 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rapid Antigen Testing (RAT) for COVID-19 Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rapid Antigen Testing (RAT) for COVID-19 Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rapid Antigen Testing (RAT) for COVID-19, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Product Type & Application
Table 12. Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rapid Antigen Testing (RAT) for COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing (RAT) for COVID-19 as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2019-2024) & (K Units)
Table 18. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2019-2024)
Table 19. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2025-2030) & (K Units)
Table 20. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2025-2030)
Table 21. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2019-2024)
Table 23. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2025-2030)
Table 25. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2024) & (K Units)
Table 27. North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2025-2030) & (K Units)
Table 28. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Type (2019-2024)
Table 51. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Type (2025-2030)
Table 52. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2019-2024)
Table 53. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2025-2030)
Table 54. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2019-2024)
Table 57. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2025-2030)
Table 58. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Type (2019-2024)
Table 59. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Type (2025-2030)
Table 60. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Application (2019-2024)
Table 61. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Application (2025-2030)
Table 62. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2019-2024)
Table 63. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2025-2030)
Table 64. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2019-2024)
Table 67. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2025-2030)
Table 68. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Application (2019-2024)
Table 69. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Rapid Antigen Testing (RAT) for COVID-19 Product
Table 74. Abbott Recent Developments/Updates
Table 75. Quidel Corporation Information
Table 76. Quidel Description and Business Overview
Table 77. Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Quidel Rapid Antigen Testing (RAT) for COVID-19 Product
Table 79. Quidel Recent Developments/Updates
Table 80. ACCESS BIO Corporation Information
Table 81. ACCESS BIO Description and Business Overview
Table 82. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product
Table 84. ACCESS BIO Recent Developments/Updates
Table 85. CTK Biotech Corporation Information
Table 86. CTK Biotech Description and Business Overview
Table 87. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 89. CTK Biotech Recent Developments/Updates
Table 90. SD Biosensor Corporation Information
Table 91. SD Biosensor Description and Business Overview
Table 92. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product
Table 94. SD Biosensor Recent Developments/Updates
Table 95. Ellume Corporation Information
Table 96. Ellume Description and Business Overview
Table 97. Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ellume Rapid Antigen Testing (RAT) for COVID-19 Product
Table 99. Ellume Recent Developments/Updates
Table 100. InBios Corporation Information
Table 101. InBios Description and Business Overview
Table 102. InBios Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. InBios Rapid Antigen Testing (RAT) for COVID-19 Product
Table 104. InBios Recent Developments/Updates
Table 105. Celltrion Corporation Information
Table 106. Celltrion Description and Business Overview
Table 107. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product
Table 109. Celltrion Recent Developments/Updates
Table 110. AESKU.GROUP Corporation Information
Table 111. AESKU.GROUP Description and Business Overview
Table 112. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product
Table 114. AESKU.GROUP Recent Developments/Updates
Table 115. ROCHE Corporation Information
Table 116. ROCHE Description and Business Overview
Table 117. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product
Table 119. ROCHE Recent Developments/Updates
Table 120. BD Corporation Information
Table 121. BD Description and Business Overview
Table 122. BD Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. BD Rapid Antigen Testing (RAT) for COVID-19 Product
Table 124. BD Recent Developments/Updates
Table 125. OraSure Technologies Corporation Information
Table 126. OraSure Technologies Description and Business Overview
Table 127. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product
Table 129. OraSure Technologies Recent Developments/Updates
Table 130. Clip Health Corporation Information
Table 131. Clip Health Description and Business Overview
Table 132. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product
Table 134. Clip Health Recent Developments/Updates
Table 135. LumiraDx Corporation Information
Table 136. LumiraDx Description and Business Overview
Table 137. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product
Table 139. LumiraDx Recent Developments/Updates
Table 140. Princeton BioMeditech Corporation Corporation Information
Table 141. Princeton BioMeditech Corporation Description and Business Overview
Table 142. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product
Table 144. Princeton BioMeditech Corporation Recent Developments/Updates
Table 145. RapiGEN Inc. Corporation Information
Table 146. RapiGEN Inc. Description and Business Overview
Table 147. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product
Table 149. RapiGEN Inc. Recent Developments/Updates
Table 150. Orient Gene Corporation Information
Table 151. Orient Gene Description and Business Overview
Table 152. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product
Table 154. Orient Gene Recent Developments/Updates
Table 155. Wondfo Biotech Corporation Information
Table 156. Wondfo Biotech Description and Business Overview
Table 157. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 159. Wondfo Biotech Recent Developments/Updates
Table 160. Ihealth (Andon Health) Corporation Information
Table 161. Ihealth (Andon Health) Description and Business Overview
Table 162. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product
Table 164. Ihealth (Andon Health) Recent Developments/Updates
Table 165. Wantai BioPharm Corporation Information
Table 166. Wantai BioPharm Description and Business Overview
Table 167. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product
Table 169. Wantai BioPharm Recent Developments/Updates
Table 170. Biotest Biotech Corporation Information
Table 171. Biotest Biotech Description and Business Overview
Table 172. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 174. Biotest Biotech Recent Developments/Updates
Table 175. Shenzhen YHLO Biotech Corporation Information
Table 176. Shenzhen YHLO Biotech Description and Business Overview
Table 177. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 179. Shenzhen YHLO Biotech Recent Developments/Updates
Table 180. Vazyme Biotech Corporation Information
Table 181. Vazyme Biotech Description and Business Overview
Table 182. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 184. Vazyme Biotech Recent Developments/Updates
Table 185. EasyDiagnosis Biomedicine Corporation Information
Table 186. EasyDiagnosis Biomedicine Description and Business Overview
Table 187. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product
Table 189. EasyDiagnosis Biomedicine Recent Developments/Updates
Table 190. Beijing Hotgen Biotech Corporation Information
Table 191. Beijing Hotgen Biotech Description and Business Overview
Table 192. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 193. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 194. Beijing Hotgen Biotech Recent Developments/Updates
Table 195. Assure Tech Corporation Information
Table 196. Assure Tech Description and Business Overview
Table 197. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 198. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 199. Assure Tech Recent Developments/Updates
Table 200. Hangzhou AllTest Biotech Corporation Information
Table 201. Hangzhou AllTest Biotech Description and Business Overview
Table 202. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 203. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 204. Hangzhou AllTest Biotech Recent Developments/Updates
Table 205. ACON Biotech Corporation Information
Table 206. ACON Biotech Description and Business Overview
Table 207. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 208. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
Table 209. ACON Biotech Recent Developments/Updates
Table 210. BGI Genomics Corporation Information
Table 211. BGI Genomics Description and Business Overview
Table 212. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 213. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product
Table 214. BGI Genomics Recent Developments/Updates
Table 215. Lepu Medical Technology Corporation Information
Table 216. Lepu Medical Technology Description and Business Overview
Table 217. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 218. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product
Table 219. Lepu Medical Technology Recent Developments/Updates
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Rapid Antigen Testing (RAT) for COVID-19 Distributors List
Table 223. Rapid Antigen Testing (RAT) for COVID-19 Customers List
Table 224. Rapid Antigen Testing (RAT) for COVID-19 Market Trends
Table 225. Rapid Antigen Testing (RAT) for COVID-19 Market Drivers
Table 226. Rapid Antigen Testing (RAT) for COVID-19 Market Challenges
Table 227. Rapid Antigen Testing (RAT) for COVID-19 Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rapid Antigen Testing (RAT) for COVID-19
Figure 2. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Type in 2023 & 2030
Figure 4. Fluorescence Immunochromatography Product Picture
Figure 5. Colloidal Gold Immunochromatography Product Picture
Figure 6. Latex Immunochromatography Product Picture
Figure 7. Others Product Picture
Figure 8. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Community Testing
Figure 12. Other
Figure 13. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size (2019-2030) & (US$ Million)
Figure 15. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (2019-2030) & (K Units)
Figure 16. Global Rapid Antigen Testing (RAT) for COVID-19 Average Price (US$/Unit) & (2019-2030)
Figure 17. Rapid Antigen Testing (RAT) for COVID-19 Report Years Considered
Figure 18. Rapid Antigen Testing (RAT) for COVID-19 Sales Share by Manufacturers in 2023
Figure 19. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Rapid Antigen Testing (RAT) for COVID-19 Players: Market Share by Revenue in 2023
Figure 21. Rapid Antigen Testing (RAT) for COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2019-2030)
Figure 24. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2019-2030)
Figure 28. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 29. Germany Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2019-2030)
Figure 36. China Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2019-2030)
Figure 47. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Type (2019-2030)
Figure 57. Global Revenue Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Type (2019-2030)
Figure 58. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Application (2019-2030)
Figure 60. Global Revenue Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Application (2019-2030)
Figure 61. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Application (2019-2030)
Figure 62. Rapid Antigen Testing (RAT) for COVID-19 Value Chain
Figure 63. Rapid Antigen Testing (RAT) for COVID-19 Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
